Obstetrics & Gynecology

News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Cancer Evolution Study Reveals Biology of Glioma Progression

illustration of a brain tumor in a man

A form of glioma, a type of brain cancer, tends to progress towards greater malignancy due to an increasing tendency of the glioma cells to transform into immature, stem-cell-like states, according to a study led by investigators at Weill Cornell Medicine, the New York Genome Center, Harvard Medical School and Mass General Brigham. The findings showcase the power of modern laboratory technology for illuminating cancer development and could inform future treatments and prognostic measures for gliomas.

Dr. Dan Landau

Dr. Dan Landau. Credit: Roger Tully

BioVenture eLab Secures $1.5 Million State Grant to Broaden Weill Cornell Entrepreneurial Ecosystem

A man wearing business attire is speaking at a podium in front of an audience.

Weill Cornell Medicine has received a four-year, $1.5 million grant from New York’s Empire State Development to increase resources available through BioVenture eLab, the institution’s hub for biomedical entrepreneurship. The grant is among the first the state has awarded through its New York Global Entrepreneurs Program, which was established last year to attract innovative life sciences entrepreneurs to launch or expand their businesses in New York.

BioVenture eLab aims to generate entrepreneurship and commercialization opportunities from within the academic medical institution’s community with the state funding. It will also enable BioVenture eLab to recruit international founders in-house to help kindle enterprise expertise among Weill Cornell Medicine faculty and trainees.

“The grant allows us to combine resources from New York state as well as resources from Weill Cornell and the greater Cornell ecosystems to bring inventions that can impact patients to market,” said BioVenture eLab Director Loren Busby.

Demystifying the Molecular Mechanisms of General Anesthesia

sodium ion channel

Researchers at Weill Cornell Medicine and Birkbeck, University of London, have identified a site where a commonly used anesthetic binds to sodium ion channels, revealing a molecular mechanism that may explain how these drugs dampen communication between neurons. Ion channels are proteins that regulate the flow of charged particles across cell membranes, enabling neurons to generate electrical signals. By reducing this signaling, inhaled anesthetics help suppress brain activity, producing unconsciousness and immobility during surgery.

Hugh Hemmings

Dr. Hugh Hemmings

The findings, published June 19 in Nature Communications, shed light on a longstanding mystery: For 175 years, doctors have safely used inhaled anesthetics to render patients unconscious, but didn’t fully understand how these drugs work.

Contact Us